HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.

Citation data:

Diabetes care, ISSN: 1935-5548, Vol: 38, Issue: 12, Page: 2285-92

Publication Year:
2015
Usage 325
Abstract Views 238
Link-outs 69
Full Text Views 18
Captures 82
Exports-Saves 48
Readers 34
Social Media 8
Tweets 8
Citations 13
Citation Indexes 13
Repository URL:
https://hsrc.himmelfarb.gwu.edu/biostatscenter_facpubs/187; https://hsrc.himmelfarb.gwu.edu/biostatscenter_facpubs/137
PMID:
26537182
DOI:
10.2337/dc15-0848
PMCID:
PMC4657618
ClinicalTrials.gov Identifier:
NCT00081328
Author(s):
Zeitler, Phil; Hirst, Kathryn; Copeland, Kenneth C; El Ghormli, Laure; Levitt Katz, Lorraine; Levitsky, Lynne L; Linder, Barbara; McGuigan, Paul; White, Neil H; Wilfley, Denise; TODAY Study Group Show More Hide
Publisher(s):
American Diabetes Association
Tags:
Medicine; Nursing; Diabetes Mellitus; Type 2--drug therapy; Hemoglobin A; Glycosylated--analysis; Hypoglycemic Agents--therapeutic use; Diabetes Mellitus, Type 2--drug therapy; Hemoglobin A, Glycosylated--analysis; Hypoglycemic Agents--therapeutic use; Biostatistics; Epidemiology
Most Recent Tweet View All Tweets
article description
To determine whether clinically accessible parameters early in the course of youth-onset type 2 diabetes predict likelihood of durable control on oral therapy.